Lung Cancer Surgery Market Size, Share & Industry Analysis, By Procedure Type (Lobectomy, Segmentectomy, Pneumonectomy, and Others), By Surgical Approach (Open Surgery, Video-Assisted Thoracoscopic Surgery (VATS), and Robotic-Assisted Thoracic Surgery (RATS)), By Cancer Type (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)), By Provider (Hospitals, Cancer Care Centers, and Others), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI115411

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Lung Cancer, Key Countries/Regions, 2023/2024
2. Number of Lung Cancer Surgical Procedures, Key Countries/Regions, 2023/2024
3. Key Industry Developments - Mergers, Acquisitions & Partnerships
Global Lung Cancer Surgery Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Procedure Type
  1. Lobectomy
  2. Segmentectomy
  3. Pneumonectomy
  4. Others
2. Market Analysis, Insights and Forecast – By Surgical Approach
  1. Open Surgery
  2. Video-Assisted Thoracoscopic Surgery (VATS)
  3. Robotic-Assisted Thoracic Surgery (RATS)
3. Market Analysis, Insights and Forecast – By Cancer Type
  1. Non–Small Cell Lung Cancer (NSCLC)
  2. Small Cell Lung Cancer (SCLC)
4. Market Analysis, Insights and Forecast – By Provider
  1. Hospitals
  2. Cancer Care Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Lung Cancer Surgery Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Procedure Type
  1. Lobectomy
  2. Segmentectomy
  3. Pneumonectomy
  4. Others
2. Market Analysis, Insights and Forecast – By Surgical Approach
  1. Open Surgery
  2. Video-Assisted Thoracoscopic Surgery (VATS)
  3. Robotic-Assisted Thoracic Surgery (RATS)
3. Market Analysis, Insights and Forecast – By Cancer Type
  1. Non–Small Cell Lung Cancer (NSCLC)
  2. Small Cell Lung Cancer (SCLC)
4. Market Analysis, Insights and Forecast – By Provider
  1. Hospitals
  2. Cancer Care Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Cancer Type
  2. Canada
    1. By Cancer Type
Europe Lung Cancer Surgery Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Procedure Type
  1. Lobectomy
  2. Segmentectomy
  3. Pneumonectomy
  4. Others
2. Market Analysis, Insights and Forecast – By Surgical Approach
  1. Open Surgery
  2. Video-Assisted Thoracoscopic Surgery (VATS)
  3. Robotic-Assisted Thoracic Surgery (RATS)
3. Market Analysis, Insights and Forecast – By Cancer Type
  1. Non–Small Cell Lung Cancer (NSCLC)
  2. Small Cell Lung Cancer (SCLC)
4. Market Analysis, Insights and Forecast – By Provider
  1. Hospitals
  2. Cancer Care Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
    1. By Cancer Type
  2. Germany
    1. By Cancer Type
  3. France
    1. By Cancer Type
  4. Spain
    1. By Cancer Type
  5. Italy
    1. By Cancer Type
  6. Scandinavia
    1. By Cancer Type
  7. Rest of Europe
    1. By Cancer Type
Asia Pacific Lung Cancer Surgery Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Procedure Type
  1. Lobectomy
  2. Segmentectomy
  3. Pneumonectomy
  4. Others
2. Market Analysis, Insights and Forecast – By Surgical Approach
  1. Open Surgery
  2. Video-Assisted Thoracoscopic Surgery (VATS)
  3. Robotic-Assisted Thoracic Surgery (RATS)
3. Market Analysis, Insights and Forecast – By Cancer Type
  1. Non–Small Cell Lung Cancer (NSCLC)
  2. Small Cell Lung Cancer (SCLC)
4. Market Analysis, Insights and Forecast – By Provider
  1. Hospitals
  2. Cancer Care Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
    1. By Cancer Type
  2. Australia
    1. By Cancer Type
  3. China
    1. By Cancer Type
  4. India
    1. By Cancer Type
  5. Southeast Asia
    1. By Cancer Type
  6. Rest of Asia Pacific
    1. By Cancer Type
Latin America Lung Cancer Surgery Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Procedure Type
  1. Lobectomy
  2. Segmentectomy
  3. Pneumonectomy
  4. Others
2. Market Analysis, Insights and Forecast – By Surgical Approach
  1. Open Surgery
  2. Video-Assisted Thoracoscopic Surgery (VATS)
  3. Robotic-Assisted Thoracic Surgery (RATS)
3. Market Analysis, Insights and Forecast – By Cancer Type
  1. Non–Small Cell Lung Cancer (NSCLC)
  2. Small Cell Lung Cancer (SCLC)
4. Market Analysis, Insights and Forecast – By Provider
  1. Hospitals
  2. Cancer Care Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
    1. By Cancer Type
  2. Mexico
    1. By Cancer Type
  3. Rest of Latin America
    1. By Cancer Type
Middle East & Africa Lung Cancer Surgery Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Procedure Type
  1. Lobectomy
  2. Segmentectomy
  3. Pneumonectomy
  4. Others
2. Market Analysis, Insights and Forecast – By Surgical Approach
  1. Open Surgery
  2. Video-Assisted Thoracoscopic Surgery (VATS)
  3. Robotic-Assisted Thoracic Surgery (RATS)
3. Market Analysis, Insights and Forecast – By Cancer Type
  1. Non–Small Cell Lung Cancer (NSCLC)
  2. Small Cell Lung Cancer (SCLC)
4. Market Analysis, Insights and Forecast – By Provider
  1. Hospitals
  2. Cancer Care Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
    1. By Cancer Type
  2. South Africa
    1. By Cancer Type
  3. Rest of Middle East & Africa
    1. By Cancer Type
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. HCA Healthcare
  2. Cleveland Clinic
  3. Chesapeake Regional Health
  4. Mayo Clinic
  5. MD Anderson Cancer Center
  6. Ramsay Health Care
  7. Spire Healthcare Group plc
  8. Fortis Healthcare
  9. National Cancer Center Japan
  10. Tata Memorial Centre

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Lung Cancer, Key Countries/Regions, 2023/2024
2. Number of Lung Cancer Surgical Procedures, Key Countries/Regions, 2023/2024
3. Key Industry Developments - Mergers, Acquisitions & Partnerships
Global Lung Cancer Surgery Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Procedure Type
  1. Lobectomy
  2. Segmentectomy
  3. Pneumonectomy
  4. Others
2. Market Analysis, Insights and Forecast – By Surgical Approach
  1. Open Surgery
  2. Video-Assisted Thoracoscopic Surgery (VATS)
  3. Robotic-Assisted Thoracic Surgery (RATS)
3. Market Analysis, Insights and Forecast – By Cancer Type
  1. Non–Small Cell Lung Cancer (NSCLC)
  2. Small Cell Lung Cancer (SCLC)
4. Market Analysis, Insights and Forecast – By Provider
  1. Hospitals
  2. Cancer Care Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Lung Cancer Surgery Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Procedure Type
  1. Lobectomy
  2. Segmentectomy
  3. Pneumonectomy
  4. Others
2. Market Analysis, Insights and Forecast – By Surgical Approach
  1. Open Surgery
  2. Video-Assisted Thoracoscopic Surgery (VATS)
  3. Robotic-Assisted Thoracic Surgery (RATS)
3. Market Analysis, Insights and Forecast – By Cancer Type
  1. Non–Small Cell Lung Cancer (NSCLC)
  2. Small Cell Lung Cancer (SCLC)
4. Market Analysis, Insights and Forecast – By Provider
  1. Hospitals
  2. Cancer Care Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Cancer Type
  2. Canada
    1. By Cancer Type
Europe Lung Cancer Surgery Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Procedure Type
  1. Lobectomy
  2. Segmentectomy
  3. Pneumonectomy
  4. Others
2. Market Analysis, Insights and Forecast – By Surgical Approach
  1. Open Surgery
  2. Video-Assisted Thoracoscopic Surgery (VATS)
  3. Robotic-Assisted Thoracic Surgery (RATS)
3. Market Analysis, Insights and Forecast – By Cancer Type
  1. Non–Small Cell Lung Cancer (NSCLC)
  2. Small Cell Lung Cancer (SCLC)
4. Market Analysis, Insights and Forecast – By Provider
  1. Hospitals
  2. Cancer Care Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
    1. By Cancer Type
  2. Germany
    1. By Cancer Type
  3. France
    1. By Cancer Type
  4. Spain
    1. By Cancer Type
  5. Italy
    1. By Cancer Type
  6. Scandinavia
    1. By Cancer Type
  7. Rest of Europe
    1. By Cancer Type
Asia Pacific Lung Cancer Surgery Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Procedure Type
  1. Lobectomy
  2. Segmentectomy
  3. Pneumonectomy
  4. Others
2. Market Analysis, Insights and Forecast – By Surgical Approach
  1. Open Surgery
  2. Video-Assisted Thoracoscopic Surgery (VATS)
  3. Robotic-Assisted Thoracic Surgery (RATS)
3. Market Analysis, Insights and Forecast – By Cancer Type
  1. Non–Small Cell Lung Cancer (NSCLC)
  2. Small Cell Lung Cancer (SCLC)
4. Market Analysis, Insights and Forecast – By Provider
  1. Hospitals
  2. Cancer Care Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
    1. By Cancer Type
  2. Australia
    1. By Cancer Type
  3. China
    1. By Cancer Type
  4. India
    1. By Cancer Type
  5. Southeast Asia
    1. By Cancer Type
  6. Rest of Asia Pacific
    1. By Cancer Type
Latin America Lung Cancer Surgery Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Procedure Type
  1. Lobectomy
  2. Segmentectomy
  3. Pneumonectomy
  4. Others
2. Market Analysis, Insights and Forecast – By Surgical Approach
  1. Open Surgery
  2. Video-Assisted Thoracoscopic Surgery (VATS)
  3. Robotic-Assisted Thoracic Surgery (RATS)
3. Market Analysis, Insights and Forecast – By Cancer Type
  1. Non–Small Cell Lung Cancer (NSCLC)
  2. Small Cell Lung Cancer (SCLC)
4. Market Analysis, Insights and Forecast – By Provider
  1. Hospitals
  2. Cancer Care Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
    1. By Cancer Type
  2. Mexico
    1. By Cancer Type
  3. Rest of Latin America
    1. By Cancer Type
Middle East & Africa Lung Cancer Surgery Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Procedure Type
  1. Lobectomy
  2. Segmentectomy
  3. Pneumonectomy
  4. Others
2. Market Analysis, Insights and Forecast – By Surgical Approach
  1. Open Surgery
  2. Video-Assisted Thoracoscopic Surgery (VATS)
  3. Robotic-Assisted Thoracic Surgery (RATS)
3. Market Analysis, Insights and Forecast – By Cancer Type
  1. Non–Small Cell Lung Cancer (NSCLC)
  2. Small Cell Lung Cancer (SCLC)
4. Market Analysis, Insights and Forecast – By Provider
  1. Hospitals
  2. Cancer Care Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
    1. By Cancer Type
  2. South Africa
    1. By Cancer Type
  3. Rest of Middle East & Africa
    1. By Cancer Type
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. HCA Healthcare
  2. Cleveland Clinic
  3. Chesapeake Regional Health
  4. Mayo Clinic
  5. MD Anderson Cancer Center
  6. Ramsay Health Care
  7. Spire Healthcare Group plc
  8. Fortis Healthcare
  9. National Cancer Center Japan
  10. Tata Memorial Centre

Read Less

List of Figures

Figure 1: Global Lung Cancer Surgery Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Lung Cancer Surgery Market Value Share (%), by Procedure Type, 2025 & 2034

Figure 3: Global Lung Cancer Surgery Market Value Share (%), by Surgical Approach, 2025 & 2034

Figure 4: Global Lung Cancer Surgery Market Value Share (%), by Cancer Type, 2025 & 2034

Figure 5: Global Lung Cancer Surgery Market Value Share (%), by Provider, 2025 & 2034

Figure 6: Global Lung Cancer Surgery Market Value Share (%), by Region, 2025 & 2034

Figure 7: North America Lung Cancer Surgery Market Value (USD billion), by Procedure Type, 2025 & 2034

Figure 8: North America Lung Cancer Surgery Market Value Share (%), by Procedure Type, 2025

Figure 9: North America Lung Cancer Surgery Market Value (USD billion), by Surgical Approach, 2025 & 2034

Figure 10: North America Lung Cancer Surgery Market Value Share (%), by Surgical Approach, 2025

Figure 11: North America Lung Cancer Surgery Market Value (USD billion), by Cancer Type, 2025 & 2034

Figure 12: North America Lung Cancer Surgery Market Value Share (%), by Cancer Type, 2025

Figure 13: North America Lung Cancer Surgery Market Value (USD billion), by Provider, 2025 & 2034

Figure 14: North America Lung Cancer Surgery Market Value Share (%), by Provider, 2025

Figure 15: North America Lung Cancer Surgery Market Value (USD billion), By Country, 2025 & 2034

Figure 16: North America Lung Cancer Surgery Market Value Share (%), By Country, 2025

Figure 17: Europe Lung Cancer Surgery Market Value (USD billion), by Procedure Type, 2025 & 2034

Figure 18: Europe Lung Cancer Surgery Market Value Share (%), by Procedure Type, 2025

Figure 19: Europe Lung Cancer Surgery Market Value (USD billion), by Surgical Approach, 2025 & 2034

Figure 20: Europe Lung Cancer Surgery Market Value Share (%), by Surgical Approach, 2025

Figure 21: Europe Lung Cancer Surgery Market Value (USD billion), by Cancer Type, 2025 & 2034

Figure 22: Europe Lung Cancer Surgery Market Value Share (%), by Cancer Type, 2025

Figure 23: Europe Lung Cancer Surgery Market Value (USD billion), by Provider, 2025 & 2034

Figure 24: Europe Lung Cancer Surgery Market Value Share (%), by Provider, 2025

Figure 25: Europe Lung Cancer Surgery Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 26: Europe Lung Cancer Surgery Market Value Share (%), By Country/ Sub-region, 2025

Figure 27: Asia Pacific Lung Cancer Surgery Market Value (USD billion), by Procedure Type, 2025 & 2034

Figure 28: Asia Pacific Lung Cancer Surgery Market Value Share (%), by Procedure Type, 2025

Figure 29: Asia Pacific Lung Cancer Surgery Market Value (USD billion), by Surgical Approach, 2025 & 2034

Figure 30: Asia Pacific Lung Cancer Surgery Market Value Share (%), by Surgical Approach, 2025

Figure 31: Asia Pacific Lung Cancer Surgery Market Value (USD billion), by Cancer Type, 2025 & 2034

Figure 32: Asia Pacific Lung Cancer Surgery Market Value Share (%), by Cancer Type, 2025

Figure 33: Asia Pacific Lung Cancer Surgery Market Value (USD billion), by Provider, 2025 & 2034

Figure 34: Asia Pacific Lung Cancer Surgery Market Value Share (%), by Provider, 2025

Figure 35: Asia Pacific Lung Cancer Surgery Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 36: Asia Pacific Lung Cancer Surgery Market Value Share (%), By Country/ Sub-region, 2025

Figure 37: Latin America Lung Cancer Surgery Market Value (USD billion), by Procedure Type, 2025 & 2034

Figure 38: Latin America Lung Cancer Surgery Market Value Share (%), by Procedure Type, 2025

Figure 39: Latin America Lung Cancer Surgery Market Value (USD billion), by Surgical Approach, 2025 & 2034

Figure 40: Latin America Lung Cancer Surgery Market Value Share (%), by Surgical Approach, 2025

Figure 41: Latin America Lung Cancer Surgery Market Value (USD billion), by Cancer Type, 2025 & 2034

Figure 42: Latin America Lung Cancer Surgery Market Value Share (%), by Cancer Type, 2025

Figure 43: Latin America Lung Cancer Surgery Market Value (USD billion), by Provider, 2025 & 2034

Figure 44: Latin America Lung Cancer Surgery Market Value Share (%), by Provider, 2025

Figure 45: Latin America Lung Cancer Surgery Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 46: Latin America Lung Cancer Surgery Market Value Share (%), By Country/ Sub-region, 2025

Figure 47: Middle East & Africa Lung Cancer Surgery Market Value (USD billion), by Procedure Type, 2025 & 2034

Figure 48: Middle East & Africa Lung Cancer Surgery Market Value Share (%), by Procedure Type, 2025

Figure 49: Middle East & Africa Lung Cancer Surgery Market Value (USD billion), by Surgical Approach, 2025 & 2034

Figure 50: Middle East & Africa Lung Cancer Surgery Market Value Share (%), by Surgical Approach, 2025

Figure 51: Middle East & Africa Lung Cancer Surgery Market Value (USD billion), by Cancer Type, 2025 & 2034

Figure 52: Middle East & Africa Lung Cancer Surgery Market Value Share (%), by Cancer Type, 2025

Figure 53: Middle East & Africa Lung Cancer Surgery Market Value (USD billion), by Provider, 2025 & 2034

Figure 54: Middle East & Africa Lung Cancer Surgery Market Value Share (%), by Provider, 2025

Figure 55: Middle East & Africa Lung Cancer Surgery Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 56: Middle East & Africa Lung Cancer Surgery Market Value Share (%), By Country/ Sub-region, 2025

Figure 57: Global Lung Cancer Surgery Market Share (%), By Company, 2025

List of Tables

Table 1: Global Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Procedure Type, 2021–2034

Table 2: Global Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Surgical Approach, 2021–2034

Table 3: Global Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 4: Global Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Provider, 2021–2034

Table 5: Global Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Region, 2021–2034

Table 6: North America Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Procedure Type, 2021–2034

Table 7: North America Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Surgical Approach, 2021–2034

Table 8: North America Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 9: North America Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Provider, 2021–2034

Table 10: North America Lung Cancer Surgery Market Revenue (USD billion) Forecast, By Country, 2021–2034

Table 11: U.S. Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 12: Canada Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 13: Europe Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Procedure Type, 2021–2034

Table 14: Europe Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Surgical Approach, 2021–2034

Table 15: Europe Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 16: Europe Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Provider, 2021–2034

Table 17: Europe Lung Cancer Surgery Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 18: Germany Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 19: U.K. Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 20: France Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 21: Italy Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 22: Spain Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 23: Scandinavia Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 24: Rest of Europe Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 25: Asia Pacific Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Procedure Type, 2021–2034

Table 26: Asia Pacific Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Surgical Approach, 2021–2034

Table 27: Asia Pacific Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 28: Asia Pacific Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Provider, 2021–2034

Table 29: Asia Pacific Lung Cancer Surgery Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 30: China Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 31: Japan Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 32: India Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 33: Australia Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 34: Southeast Asia Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 35: Rest of Asia Pacific Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 36: Latin America Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Procedure Type, 2021–2034

Table 37: Latin America Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Surgical Approach, 2021–2034

Table 38: Latin America Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 39: Latin America Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Provider, 2021–2034

Table 40: Latin America Lung Cancer Surgery Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 41: Brazil Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 42: Mexico Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 43: Rest of Latin America Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 44: Middle East & Africa Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Procedure Type, 2021–2034

Table 45: Middle East & Africa Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Surgical Approach, 2021–2034

Table 46: Middle East & Africa Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 47: Middle East & Africa Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Provider, 2021–2034

Table 48: Middle East & Africa Lung Cancer Surgery Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 49: GCC Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 50: South Africa Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

Table 51: Rest of Middle East & Africa Lung Cancer Surgery Market Revenue (USD billion) Forecast, by Cancer Type, 2021–2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 261

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

India Biogas Market

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com